• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过透析预后与实践模式研究(DOPPS)中血液透析实践的变化来解释血液透析患者死亡率的国际趋势。

Explaining International Trends in Mortality on Hemodialysis Through Changes in Hemodialysis Practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

作者信息

McCullough Keith P, Morgenstern Hal, Rayner Hugh C, Port Friedrich K, Jadoul Michel Y, Akizawa Tadao, Pisoni Ronald L, Herman William H, Robinson Bruce M

机构信息

Arbor Research Collaborative for Health, Ann Arbor, Michigan.

Department of Epidemiology, Ann Arbor, Michigan; Department of Environmental Health Sciences, School of Public Health, Ann Arbor, Michigan; Department of Urology, Ann Arbor, Michigan.

出版信息

Am J Kidney Dis. 2025 Jan;85(1):25-35.e1. doi: 10.1053/j.ajkd.2024.06.017. Epub 2024 Aug 9.

DOI:10.1053/j.ajkd.2024.06.017
PMID:39127399
Abstract

RATIONALE & OBJECTIVE: Case-mix adjusted hemodialysis mortality has decreased since 1998. Many factors that influence mortality may have contributed to this trend, and these associations may differ by continental region. We studied changes in hemodialysis facility practices over time and their potential role in mediating changes in patient survival.

STUDY DESIGN

Observational prospective cohort study.

SETTING & PARTICIPANTS: Adult hemodialysis patients treated in 500 hemodialysis facilities participating in the Dialysis Outcomes and Practice Patterns Study (DOPPS) between 1999 and 2015 in the United States, Japan, and 4 European countries: Germany, Italy, Spain, and the United Kingdom.

PREDICTORS

Four practice measures at each facility: the percentages of patients with Kt/V≥1.2, interdialytic weight gain [IDWG]<5.7%, phosphorus<6mg/dL, and using arteriovenous fistulas (AVFs).

OUTCOME

Patient survival.

ANALYTICAL APPROACH

Mediation analyses, adjusted for case mix, were conducted using 3-year study phase as the exposure and facility practice measures as potential mediators.

RESULTS

In Europe, we observed a 13% improvement in overall case-mix adjusted survival per decade. Trends in facility practice measures, especially Kt/V and phosphorus, explained 10% improvement in case-mix survival per decade, representing 77% (10% explained of 13% improvement) of the observed improvement. In Japan, 73% of the observed 12%/decade improvement in case-mix adjusted survival could be attributed to facility practices, especially Kt/V and IDWG. In the United States, 56% of the observed 47%/decade improvement in case-mix adjusted survival could be attributed to facility practices, especially AVF use and phosphorus control.

LIMITATIONS

Unmeasured changes in the characteristics of the patient population over this period may confound the observed associations.

CONCLUSIONS

The improvements in adjusted hemodialysis patient survival in Europe, Japan, and the United States from 1999 to 2015 can be largely explained by improvements in specific facility practices. Future changes in patient survival may be responsive to further evolution in the implementation of common clinical practices.

PLAIN-LANGUAGE SUMMARY: Case-mix adjusted survival of patients treated with hemodialysis has improved over the last 2 decades in the United States, Japan, and Europe. Some of this improvement can be explained by region-specific changes in 4 dialysis practices, namely increases in the proportions of patients achieving (1) Kt/V≥1.2, (2) serum phosphorus levels<6mg/dL, (3) interdialytic weight gain<5.7% of body weight, and/or (4) use of arteriovenous fistulas as vascular access, with the magnitude varying according to region-specific trends in these practices. These findings suggest that further improvement in these practice measures may be attended by further reductions in mortality among patients treated with maintenance hemodialysis.

摘要

原理与目的

自1998年以来,病例组合调整后的血液透析死亡率有所下降。许多影响死亡率的因素可能导致了这一趋势,并且这些关联可能因大陆地区而异。我们研究了血液透析机构的实践随时间的变化及其在介导患者生存变化中的潜在作用。

研究设计

观察性前瞻性队列研究。

设置与参与者

1999年至2015年间在美国、日本以及4个欧洲国家(德国、意大利、西班牙和英国)的500家参与透析结果和实践模式研究(DOPPS)的血液透析机构接受治疗的成年血液透析患者。

预测因素

每个机构的四项实践指标:Kt/V≥1.2的患者百分比、透析间期体重增加[IDWG]<5.7%、血磷<6mg/dL以及使用动静脉内瘘(AVF)。

结果

患者生存情况。

分析方法

使用3年研究阶段作为暴露因素,机构实践指标作为潜在中介因素,进行病例组合调整后的中介分析。

结果

在欧洲,我们观察到每十年总体病例组合调整后的生存率提高了13%。机构实践指标的趋势,尤其是Kt/V和血磷,解释了每十年病例组合生存率提高的10%,占观察到的改善的77%(13%的改善中10%得到解释)。在日本,观察到的病例组合调整后生存率每十年提高12%,其中73%可归因于机构实践,尤其是Kt/V和IDWG。在美国,观察到的病例组合调整后生存率每十年提高47%,其中56%可归因于机构实践,尤其是AVF的使用和血磷控制。

局限性

在此期间患者人群特征的未测量变化可能会混淆观察到的关联。

结论

1999年至2015年期间,欧洲、日本和美国血液透析患者调整后生存率的提高在很大程度上可以通过特定机构实践的改善来解释

相似文献

1
Explaining International Trends in Mortality on Hemodialysis Through Changes in Hemodialysis Practices in the Dialysis Outcomes and Practice Patterns Study (DOPPS).通过透析预后与实践模式研究(DOPPS)中血液透析实践的变化来解释血液透析患者死亡率的国际趋势。
Am J Kidney Dis. 2025 Jan;85(1):25-35.e1. doi: 10.1053/j.ajkd.2024.06.017. Epub 2024 Aug 9.
2
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际间血液透析用动静脉通路位置与使用的差异:来自透析结局和实践模式研究(DOPPS)的结果。
Am J Kidney Dis. 2018 Apr;71(4):469-478. doi: 10.1053/j.ajkd.2017.09.012. Epub 2017 Dec 1.
3
Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).透析间期体重增加:国际透析结局和实践模式研究(DOPPS)中的趋势、预测因素和相关结局。
Am J Kidney Dis. 2017 Mar;69(3):367-379. doi: 10.1053/j.ajkd.2016.08.030. Epub 2016 Nov 17.
4
International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际 natives arteriovenous 瘘通畅率和无导管时间的比较:来自透析结局和实践模式研究 (DOPPS) 的结果。
Am J Kidney Dis. 2021 Feb;77(2):245-254. doi: 10.1053/j.ajkd.2020.06.020. Epub 2020 Sep 21.
5
Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis.参与透析预后与实践模式研究(DOPPS)的国家中,医疗机构血液透析血管通路的使用情况与死亡率:一项工具变量分析
Am J Kidney Dis. 2009 Mar;53(3):475-91. doi: 10.1053/j.ajkd.2008.10.043. Epub 2009 Jan 15.
6
Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons.美国血管通路使用、患者偏好和相关实践的趋势:来自美国 DOPPS 实践监测的最新信息以及国际比较。
Am J Kidney Dis. 2015 Jun;65(6):905-15. doi: 10.1053/j.ajkd.2014.12.014. Epub 2015 Feb 7.
7
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS).错过血液透析治疗:透析结局和实践模式研究(DOPPS)中的国际差异、预测因素和结局。
Am J Kidney Dis. 2018 Nov;72(5):634-643. doi: 10.1053/j.ajkd.2018.04.019. Epub 2018 Aug 23.
8
Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS).不同血清钙、磷和甲状旁腺激素水平的透析患者的死亡风险:透析结局和实践模式研究(DOPPS)
Am J Kidney Dis. 2008 Sep;52(3):519-30. doi: 10.1053/j.ajkd.2008.03.020. Epub 2008 Jun 2.
9
Hemodialysis delivery, dialysis dose achievement, and vascular access types in hemodialysis patients from the Gulf Cooperation Council countries enrolled in the dialysis outcomes and practice patterns study phase 5 (2012-2015).参与透析结果与实践模式研究第5阶段(2012 - 2015年)的海湾合作委员会国家血液透析患者的血液透析治疗、透析剂量达成情况及血管通路类型
Saudi J Kidney Dis Transpl. 2016 Nov;27(6 Suppl 1):S42-50. doi: 10.4103/1319-2442.194889.
10
Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS).欧洲、日本和美国血液透析患者的合并症与死亡率之间的关联:透析结果和实践模式研究(DOPPS)
J Am Soc Nephrol. 2003 Dec;14(12):3270-7. doi: 10.1097/01.asn.0000100127.54107.57.

引用本文的文献

1
Insomnia, pruritus, and constipation in hemodialysis patients: a cross-sectional study.血液透析患者的失眠、瘙痒和便秘:一项横断面研究。
Front Physiol. 2025 Aug 4;16:1637989. doi: 10.3389/fphys.2025.1637989. eCollection 2025.
2
Current clinical profiles for Chinese hemodialysis patients.中国血液透析患者的当前临床概况。
Sci Rep. 2025 Aug 4;15(1):28428. doi: 10.1038/s41598-025-11951-6.
3
Mortality Trends in Patients Undergoing Hemodialysis, 2003-2021: Data from National Health Insurance Service in Korea.2003 - 2021年接受血液透析患者的死亡率趋势:来自韩国国民健康保险服务的数据。
J Clin Med. 2025 Apr 25;14(9):2987. doi: 10.3390/jcm14092987.